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SYNTHESIS OF TWO NEW CORTICOTROPHIC PEPTTOES 
CONTAINING HOMOARGININE IN POSITION 8
BY
G. I. TESSER, A. W. J. PLEUMEKERS,
W. BASSIE and I. C. BALYERT-GEERS
(Department of Organic Chemistry, Catholic University,
Toernooiveld, Nijmegen, The Netherlands)
The octadecapeptide amide I and the tetracosapeptide II containing homo- 
arginine in position 8  have been synthesized according to a generally approved 
scheme. As a new feature, the hydroxyl functions of the serine and tyrosine 
residues were protected in the synthesis of the iV-terminal decapeptide. The 
latter, presumably by its higher solubility in organic solvents, afforded the 
protected end products in an improved yield. For complete deprotection, 
however, acid-treatment of these compounds had to be extended over longer 
periods than in the absence of the ether functions.
Introüuction
The adrenal cortex and fat cells are stimulated to either steroidogenesis 
or lipolysis by the adenohypophysal hormone ACTH, which is com- 
posed of 39 amino acid residues. The aminoterminal part of this se- 
quence comprising 24 amino acid residues also displays full biological 
activity and even the shorter sequence covering the aminoterminal 
octadecapeptide suffïces to exert the effects mentioned. Apparently, 
all structural requirements essential for biological activity are present 
in the latter.
On account of experiments, in which a competitive inhibitory action 
on stimulated steroidogenesis was ascribed to smaller ACTH fragments 
comprising the basic core (the sequence 15-18), the occurrence óf two 
indispensable loei was supposed by Schwyzer1 and by Hofmann2 in 
fully active corticotrophic peptides. According to their hypothesis,
1 R. Schwyzer, P. Schiller, S. Seelig and G. Sayers, FEBS Letters 19, 232 (1971).
2  K. Hofmann, W. Wingender and F. M. Finn, Proc. Nat. Acad. Sci. USA 67, 829 (1970).
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biological information is contributed by the sequence 5-10, whereas 
binding of the hormone is induced by the basic sequence. Consequently, 
the purport of these two “sychnological words”3 should be of differing 
importance.
Our previous investigations on ACTH-analogues in which arginyl 
residues were replaced by omithyl groups fit very well into this hypo­
thesis:
a) the single replacement of arginine in position 8 by omithine4 reduced 
the biological activity to a very low level;
b) similar substitutions of the basic core, however, did not affect 
steroidogenesis and lipolysis5a and even replacement of the entire 
sequence 15-18 by tetraomithine failed to influence the hormonal 
abüity of the analogue profoundly5b.
Recently, with the analogues I and II we found that substitution in 
position 8 by homoarginine leads to compounds exhibiting a surprising 
activity on steroidogenesis and lipolysis in in vitro and in vivo experi- 
ments6. The analogues I and II* are to be considered as derivatives 
of the weakly potent analogues that arise upon insertion of lysine7 or 
ornithine in position 8. The aim of this communication is the description 
of the underlying syntheses.
(I) H-Ser-Tyr-Ser-Met-Glu-His-Phe-//ar-Trp-Gly-Lys-Pro-Val-Lys-Lys-Lys-Lys-NH2
(II) H-Ser-Tyr-Ser-Met-Glu-His-Phe-i/ar-Trp-Gly-Lys-Pro-Val-Lys-Lys-Arg-Arg-Pro- 
Val-Lys-Val-Tyr-Pro-OH
Synthetic Approach
In accordance with the general procedure recommended for the syn­
thesis of corticotrophic peptides9, the end products I and II were 
obtained in protected form by a carbodiimide mediated coupling,
* Designation and abbreviation according to the IUPAC-IUB commission on Biological 
Nomenclature8.
3 R. Schwyzer, XII. European Peptide symposion, Reinhardsbrunn (1972).
4  G. I. Tesser and W. Rittel, Rec. Trav. Chim. 88, 553 (1969).
5a G. I. Tesser and R. Schwyzer, Helv. Chim. Acta 49,1013 (1966).
5b G. I. Tesser and J. T. Buis, Rec. Trav. Chim. 90, 444 (1971).
6  G. I. Tesser, R. Maier, L. Schenkel-Hulliger, P. L. Barthe, B. Kamber and W. Rittel, 
Acta Endocrin.74, 56 (1973).
7  D. Chung and C. H. Li, J. Am. Chem. Soc. 89, 4208 (1967).
8  IUPAC-IUB Commission of Biochem. Nomenclature, Biochem. J. 126, 173 (1972).
9 R. Schwyzer and H. Kappeler, Helv. Chim. Acta 46, 1550 (1963).
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Scheme 1. Synthesis of two protected forms of [Hars]-Corticotrophin-(l-10)-decapeptide.
generating the glycyl-lysyl bond between the N-terminal decapeptide 
and the pertinent C-terminal fragments.
Key intermediate in this investigation was the delicate tetrapeptide 
ester Boc-Phe-Har(N02)-Trp-Gly-OMe (V, Scheme 1). The best way 
for its preparation turned out to be a fragment condensation using 
Mitin's method 10. Configurational homogeneity was confirmed by a 
second synthesis, in which the danger of racemization was greatly 
eliminated by use of the stepwise technique. All intermediates resisted 
crystallization, tended strongly to discoloration and had to be purified
1 0  Y .V . Mitin and O. V. Glinskaya, Tetrahedron Letters 1969, 5267.
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Scheme 2. Synthesis of a fully protected corticotrophin-(l-4)-tetrapeptide hydrazide.
by countercurrent distribution. Physical data revealed that the purifïed 
products from the two routes were identical. 
From this tetrapeptide ester, by two succesive acylations with 
Z-Glu(OBu‘)-His-N3 and either Boc-Ser-Tyr-Ser-Met-N3 or its tris- 
tert-butyl ether, the decapeptide (common to both end products) was
OBu' Boc Boc Boc Boc
Boc
Boc-
Ser-Tyr-Ser-Met-Glu-His-Phe Har-T rp-Gly-Lys-Pro-V al-Gly-Ly s-Lys- Arg-Arg-Pro-V al-Lys-V al-T yr-Pro
(XIX)
DCC/HOSu
DCC/HOSu
Bu' Bu' Bu' OBu'
I I I  1
Boc Boc Boc Boc
1 I I  1Xa
H- Lys-Pro-V al-Gly-Ly s-Lys-Arg-Arg-Pro-V al-Ly s-V al-T yr-Pro
X b -----------------------------------------------------------------------------------------
Boc Boc Boc Boc
1 I I  1
Ser-Tyr-Ser-M et-Glu-His-Phe-Har-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro
-OBu'
(XVIII)
(XX)
Xb
H-
DCC/SuOH
Boc
_ J _
Boc Boc Boc Boc
_ l___ I___ I___ I__
Lys-Pro-V al-Gly-Ly s-Lys-Ly s-Lys
Boc
Bu' Bu' Bu‘
_ 1 ___ I___ I__
OBu'
_ l___
Boc Boc Boc Boc Boc
_ l___ I___ I___ L
Ser-Tyr-Ser--Met-Glu-His-Phe-Har-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Lys-Lys
(XXII)
-NH,
(XXI)
-NH,
Scheme 3. Synthesis of two forms of protected [Har8]-corticotrophin-(l-24)-tetracosapeptide and of a protected [Har8, Lys1 7 ,1 8 ]-corti-
cotrophin-(l-l 8 )-octadecapeptide amide.
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obtained in two different protected forms Xa and Xb. The requisite 
tetrapeptide derivative, XVII, was synthesized as summarized in 
Jcheme 2, and has not yet been described. The use of a decapeptide 
derivative like Xb might be an improvement in the synthesis of cortico- 
trophins because it possesses the expected higher solubility in organic 
solvents as compared with Xa, an advantage that resulted in higher 
yields and purer products after the final condensation. Acylation of 
the known C-terminal fragments XVIII and XXI (as hydrochlorides) 
with one of the zwitter-ionic decapeptide derivatives was performed 
with dicyclohexylcarbodiimide and A^-hydroxysuccinimide (Scheme 3). 
The resulting protected corticotrophins, XIX, XX and XXII, were 
purified by countercurrent distribution. Cleavage of the tert-butyl 
functions with 90% trifluoroacetic acid proceeded smoothly'in com- 
pound XIX but longer reaction periods were required for the removal 
of all protective groups from the other two compounds. A similar 
observation has been recorded in the synthesis of calcitonin11, where 
the enhanced stability of a serine tert-butyl ether was ascribed to the 
influence of a near-by positive charge. Although no side products 
arising from this prolonged acid treatment were found, the slow acido- 
lysis evidently diminishes the advantage of the use of tert-butyl ethers 
as side chain protective groups for hydroxy amino acid residues bearing 
i  labile protective group in the a position.
After exchange of trifluoroacetate ions by acetate ions, the end 
products I and II were isolated as hexaacetates.
Experimental part
Scheme 1.
Boc-Phe-Har(N02)-Trp-Gly-()Me (V)
By fragment condensation
a) Boc-Phe-Har(N02)-O H  (III). A^-Nitrohomoarginine1 2  was esterified with metha­
nol by refluxing a 1 0  % solution of the amino acid with a mixture of thionyl chloride 
chloride and methanol (1:10 v/v prepared at —15°) for 2 j  h. After evaporation of the 
mixture and some additional evaporations with methanol to remove volatile byproducts,
1 1  B. Riniker, M. Brugger, B. Kamber, P. Sieber and W. Rittel, Helv. Chim. Acta 52, 
1058 (1969).
1 2  N. Heyboer, G. Heymens Visser and K. E. T. Kerling, Rec. Trav. Chim. 81, 69 (1962).
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the crude ester was obtained as a brittle foamy mass containing 1.36 equivalents of 
chloride. No unesterified starting material remained.
Acylation to the dipeptide ester was performed in dimethylformamide with Boc-Phe 
ONSu1 3  after careful neutralisation of the total amount of chloride present. A 10% 
molar excess of the amino component was used to ensure complete conversion of the 
activated ester. After 3 h. at room temperature, the reaction mixture was filtered and 
concentrated to a thick syrup which was diluted with water to give an oily precipitate.
The aqueous layer was separated, extracted with ethyl acetate and discarded. The 
organic phase was added to the oil and the solution was extracted with citric acid, bi- 
carbonate, and sodium chloride solutions and dried.
The product resisted crystallization. A thin layer chromatogram showed a single spot 
with chlorine-tolidine coinciding with that observed by fluorescense quenching on silica. 
Rf =  0.73 (butanol-acetic acid-water =  10: 1:3); no starting material remained.
Alkaline hydrolysis of the dipeptide ester again gave a resinous product III exhibiting 
an Rf value of 0.67 in the same solvent system. It was free from methyl ester.
b) H-Trp-Gly-OMe, HCl (IV ). 8.2 (20 mmoles) of Z-Trp-Gly-OMe1 4  were suspended 
in 80 ml of methanol and hydrogenated in the presence of 500 mg of palladium/charcoal 
(10%) and 1.82 ml (22 mmoles) of aqueous concentrated HCl. During the uptake of 
hydrogen (480 ml in about 20 min), the ester went into solution. Then 2.5 ml of pyridine 
were added (to prevent acid catalysed oxidative detoriation) and the catalyst was removed 
by filtration. The solid remaining after evaporation of the solvent was extracted with 
warm isopropanol. The off-white, noncrystalline salt was kept in the dark. Yield: 6.2 g 
(quantitative) of chromatographically pure IV, TS : RF =  0.28 (f-amylalc — isopropanol
— water =  67:26:7) =  0.51 (n-BUOH—AcOH—water =  48: 5: 14).
c) Condensation to (V): 6.95 g (14.5 mmoles) of B0 C-Phe-Har(NO2)-OH (III) were 
added to a solution of 4.5 g (15 mmoles) of H-Trp-Gly-OMè. HCl (IV), 1.53 g (22.5 
mmoles) of imidazole and 2.1 ml (15 mmoles) of triethylamine in 18 ml of dimethyl­
formamide. Subsequently 7.0 g (22.5 mmoles) of triphenyl phosphite were added and the 
mixture was stirred for 16 hours at 40°. The brown-coloured solution was then cooled 
and filtered. Dilution with diisopropyl ether afforded a brown oil, which was dissolved 
in ethyl acetate. The solution was washed with water, citric acid and bicarbonate solutions, 
dried with Na2 S 0 4  and then dropped into a tenfold volume of dry ether. The brown- 
yellow precipitate (8.96 g, 84%) was filtered and purified by countercurrent distribution 
in CHC13 —CC14  —MeOH — buffer (3 :1 :4 :2 ); buffer: 19.25 g of ammonium acetate 
and 28.5 ml of acetic acid made up to 1000 ml with water. After 375 transfers 7.1 g of a 
chromatographically pure product (K =  0.25; rmax =  57) was obtained. TS : RF =  0.54 
(CHCI3  — MeOH = 4 :1), = 0.93 (CHC1? -  M eO H - A c 0 H - H 20  =  25 : 15 : 4: 2); 
M d 0  —19.8° (c =  1, MeOH); specific rotation strongly dependent on temperature.
By stepwise synthesis
a) Boc-Har(N02)-Trp-Gly-OMe: in the same way as described for the dipeptide III 
in the foregoing preparation, Boc-Har(N02 )-OH, an amorphous compound obtained 
from A^-nitrohomoarginine1 2  by acylation with Boc-N3  according to Schnabel15, was
1 3  G. W. Anderson, J. E. Zimmerman and F. M. Callahan, J. Am. Chem. Soc. 8 6 , 1839 
1964).
1 4  K. Hofmann, M. E. Woolner, G. Spühler and E. T. Schwartz, J. Am. Chem. Soc. 80, 
1486 (1958).
1 5  E. Schnabel, Liebigs Ann. Chem. 702, 188 (1967).
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coupled with H-Trp-Gly-OMe using triphenyl phosphite. The resulting tripeptide ester 
was precipitated with ether and the oily precipitate purified by extraction of an ethyl 
.cetate solution with water, citric acid, bicarbonate, and saturated sodium chloride 
solutions. It remained as a yellow oil, that solidified upon cooling (72 %), and seemed 
chromatographically pure. T S : RF =  0.55 (CHC13  —MeOH = 4 :1 ) ;  = 0.23 (benzene
— acetone =  7:3). The yellow contamination was eliminated by countercurrent distri- 
bution in CHC13  — CC13  — MeOH -  buffer (6 : 8 :1 :4); composition of the buffer as 
before. After 387 transfers (214 in an open system and 173 in circulation) a colourless 
product could be isolated (K =  0,36, rmax =  105). A yellow compound remained in the 
first tubes. Yield of pure protected tripeptide ester 6 8 %, m.p. 122-123,5°; [a]“ =  —13.6° 
(c =  2.6 in DMF), =  -21.7° (c =  0.98 in MeOH).
Found : C 52.3 ; H 6.3 ; N 17.9 .
Calc for C26H38N80 8(590.63) : C 52.87; H6.49; N 18.97.
C25H 38N8O8 -iAcOH(620.74): 52.22; 6.49; 18.05.
b) 8.85 g (15 mmoles) of this protected tripeptide ester were dissolved in 20 ml of 
methanol, and mixed under nitrogen with 20 ml of 5.6 N  HC1 in methanol. Nitrogen 
was bubbled through the solution for 30 minutes. The solvent was then evaporated 
in vacuo. To remove volatile constituents, the residue was again dissolved in methanol 
and evaporated. This procedure was repeated twice with methanol and twice with 
<er?-butanol. Finally the free ester solidified as a brown crystalline mass, which was 
exceedingly hygroscopic and contained more than one equivalent of hydrochloric acid. 
The crude tripeptide ester was dissolved in dimethylformamide, giving a slightly acidic 
solution; it was carefully neutralized by dropwise addition of triethylamine. Then an 
additional equivalent of triethylamine and 4.5 g (15 mmoles) of Boc-Phe-OSu were added. 
The mixture was left overnight at room temperature. It was filtered and the solution 
was slowly dropped into 250 ml of water, with stirring. Filtration gave 9.8 g (89 %) of the 
crude tetrapeptide ester V. Countercurrent distribution in the system CHC13  — MeOH — 
CC14-  buffer (3 :4 :1 : 2) gave after 375 transfers an analytically pure sample in the 
elements 40-75 (K =  0.18 rm„  =  55). After crystallization from hot ethyl acetate, 
a gelatinous solid was obtained, melting at 160-163°, [a]ë 9  =  —18.9° (c =  1.05 in 
MeOH); TS : RF =  0,61 (CHC13  -  MeOH = 4 :1 ); =  0.73 (BuOH -  AcOH -  water 
=  10 :1 :  3).
Found : C 57.25; H 6.4 ; N 17.1 .
Calc. for C35H4VN 90 9(737.83): 56.98; 6.62; 17.09.
H-Phe-Har(N02)-Trp-GIy-0Me (VI). 7.38 g (10 mmoles) of the former product were 
deprotected with methanolic HC1 as described for the corresponding tripeptide ester. 
Evaporation in vacuo left a dark oil. The ester hydrochloride was converted into the 
free amine by the procedure given by Schwyzer16. The resulting yellow solid was dried 
in air yielding 5.35 g (84%) of VI. The free base could be converted into a crystalline salt 
by treatment of its methanolic solution ( 2 0  %) with oxalic acid in methanol .Again a 
brown oil separated, which crystallized upon cooling in the refrigerator overnight. 
The solid was again dissolved in methanol, enough to give a 4% solution and repreci- 
pitated by addition of isopropanol. Repetition of this procedure yielded an analytically 
pure product. TS : RF = 0.27 (BuOH — AcOH — water =  10 :1 :3 ); [a]jj5  =  —10.3 
(c =  1, MeOH).
1 6  R. Schwyzer and H. Kappeler, Helv. Chim. Acta 44, 1991 (1961).
1218 G. I. Tesser et al.
Part of this material was subjected to countercurrent distribution over 240 transfers. 
The product migrated as a single peak in the system n-butanol-petroleum ether (60-80)- 
acetic acid — water =  4: 1 : 1 :4  (K =  0,54 and rmax =  27). It was isolated by lyophiliza 
tion from /erf.-butanol.
Found : C 58.9 ; H 5.7 ; N 17.25.
Calc. for C 3 0 H 3 9 N 9 O 7 —C 2 H 2 0 4  : 58.82; 5.68; 17.32.
Z-Glu(0Bu')-His-Phe-Har(N02)-Trp-Gly-0H (VII). Acylation of the tetrapeptide 
ester VI with benzyloxycarbonyl-y-ferf-butoxyglutamyl-histidine azide was carried out 
with slight modifications according to Schwyzer16; tert-baty\ nitrite was used as the 
source of nitrosonium ions as described by Honzl and Rudinger1 7  and the azide was 
used in situ. The crude hexapeptide ester was produced in nearly quantitative yield and 
was hydrolyzed without further characterization by alkaline saponifïcation. The free 
acid VII appeared to be more readily soluble than the corresponding peptide derivative 
containing nitroarginine16: it precipitated incompletely on acidification of the alkaline 
reaction mixture. By concentration of the mother liquor, however, a second precipitate 
was obtained giving a total yield of 80 % based on the amount of tetrapeptide ester used. 
Although no contaminants could be detected on TLC, the product stubbornly resisted 
complete hydrogenolysis in the next step, unless purifïed by countercurrent distribution. 
In the solvent system CHC13  — MeOH — CC14  — buffer (7 :10: 2 ; 4) after 115 transfers, 
the compound was located in the elements 55-80 (K =  1.4rmax =  67). The purifïed 
product VII melted at 201-204° [<x]ë5 =  11.4° (c =  1.03 in AcOH 90%); =  -23 .6  
(c =  2, DMF). TS : RF =  0.34 (BuOH -  AcOH -  water =  10 :1 : 3); =  0.34 (<-amyl 
alcohol —isopropanol—water =  51 :21:28); =  0.56 (s-BuOH — AcOH — water = 
67 :10 : 23); =  0.27 (E tO A c-P y r-A cO H -w a te r =  62 : 21: 6  :11).
H-Glu(OBul) -His-Phe-Har-Trp-Gly-OH (IX ) . For the removal of iV-protecting groups, 
the hexapeptide derivative VII was dissolved in peroxide-free acetic acid (90%) and 
hydrogenated in the presence of palladium charcoal (10 %). Apparently, hydrogenolysis 
of the benzyloxycarbonyl group proceeded much faster than that of the nitro group: 
following the progress of the reaction chromatographically on Kieselgel-G (Merck) in 
methanol, the protected peptide (RF =  0.8) appeared to be converted into an inter- 
mediate (RF =  0.5) containing the nitroguanidino function before the end product 
(RF =  0.2) arose. After 30 hours the reaction was complete and slightly more than the 
theoretical amount of hydrogen had been taken up. The solution was fïltered, the solvent 
evaporated and the residue dissolved in methanol. Dilution with ether gave the partially 
protected hexapeptide IX in nearly quantitative yield. [a ] ^ 2  =  —24.8° (c =  1 DMF), 
=  12.5° (c =  1, 90% AcOH); TS: RF =  0.11 (sec-BuOH-AcOH-water =  67:10:23), 
=  0.32 (n-B uO H -Pyr-A cO H -w ater =  40: 24: 6 : 30), =  0.47 (CHCl3-M eO H -17%  
N H 3  =  41:41:18). Electrophoresis on cellulose at pH =  4.6 (pyridine acetate) revealed 
one spot, moving towards the cathode.
Boc-Ser-Tyr-Ser-Met-Glu(OBu')-His-Phe-Har-Trp-Gly-OH (Xa). According to 
Schwyzer’s procedure16, this compound was synthesized from 0.60 g (1 mmole) of 
Boc-Ser-Tyr-Ser-Met-N2 H 3  and 0.68 g (0.71 mmole) of the hexapeptide derivative IX, 
using sodium nitrite. The yield, after crystallization from hot 90% methanol was 0.53 g 
(51 %); M è 2  =  -16.4° (c =  0.7 AcOH); TS (Kieselgel-G, Merck): RF =  0.25 (B uO H - 
AcOH — water =  10 :1 : 3).
1 7  J. Honzl and J. Rudinger, Coll. Czech. Chem. Commun. 26, 2333 (1961).
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Boc-Ser(Bu1) - Tyr(Bit')-Ser(Bu')-M et-Glu(OBu1)-His-Phe-Har-Trp-Gly-OH (Xb). 
1.04 g (1.36 mmole) of the protected tetrapeptide hydrazide (XVIII, scheme 2) was 
.onverted into the corresponding azide VUIb and coupled with 1.3 g (1.36 mmole) of 
the hexapeptide tert-butyl ester acetate according to Honzl and Rudinger’s general 
insitu procedure17. The yield was 1.80 g (76%); T S : RF =  0.33 (BuOH—AcOH — 
water =  1 0 :1 : 3), =  0.36 (BuOH —AcOH—water =  67 :10: 23), =  0.50 (jec-BuOH — 
isopropanol—9 % monochloroacetic acid =  58 : 8  : 34), =  0.70 («-BuOH — Pyr—AcOH 
water =  38 : 24: 8  : 30); [a]ê° =  -14.5° (c =  1, MeOH). The Tyr/Trp ratio (0.9) after 
treatment with 90% TFA during 15 minutes points to the presence of about 5 % of the 
hexapeptide in the crude decapeptide derivative. It was used as such for the preparation 
of XX and XXII. A sample (100 mg) was subjected to the “short column” chromato- 
graphic technique of Hunt and Rigby1S. With the solvent system butanol -  acetic acid -  
water (67 :10: 23) at a pressure of 30 cm of mercury chromatographically pure material 
(67 mg) was eluted in a sharp band comprising about 2 ml. Even a trace of decapeptide 
derivative containing oxidized methionine in position 4 was retained. The product 
gave a correct Tyr/Trp ratio.
Scheme 2.
Z-Tyr(Bul)-Ser(Bu')-OMe (XI). 2.76 g of jV-Benzyloxycarbonyl-O-ferZ-butyltyrosine 
dicyclohexylammonium salt1 9  (5 mmoles) and 1.06 g of 0-/erf-butylserine methyl ester 
monohydrochloride (from the corresponding benzyloxycarbonyl compound18, after 
hydrogenolysis and acidifïcation with etheral HC1) were dissolved in 30 ml of chloroform. 
The solution was cooled to 0° and 1.03 g (5 mmoles) of dicyclohexylcarbodiimide were 
added.
The reaction mixture was left in a refrigerator for 16 hours and filtered. The fïltrate 
was evaporated in vacuo, the residue triturated with ether, filtered and the solvent was 
again removed in vacuo. The crude, crystalline dipeptide ester was dissolved in ethyl 
acetate and its solution extracted with water, citric acid solution (5%), saturated bi- 
carbonate solution and dried. The product was further purified by crystallization from 
ether by the addition of petroleum ether (60-80). Yield: 2.35 g (8 6 %); [a ] § 5 =  +5.4° 
(c =  1, MeOH). Chromatographically homogeneous, TS: RF =  0.73 (CHC13  — MeOH =
4 : 1), fluorescence quenching coincident with the chlorine-tolidine positive spot.
Found : C 65.5 ; H 7.6 ; N 5.4 .
Calc. for C29H40N2O7(528.63): C 65.89; H7.63; N  5.30.
Boc-Ser(Bu')-Tyr(Bu') -Ser(Bu') -N2H 3 (X IV ).
a) Methyl ester (X III). 2.73 g (5.16 mmoles) of the preceeding compound were 
rapidly hydrogenated in methanol using 300 mg of palladium/charcoal (10%). The 
uptake of hydrogen stopped abrubtly when 125 ml had been absorbed (100 %). An 
equivalent amount of iV-butyloxycarbonyl-O-ïerf-butylserine1 8  was added to the filtered 
methanolic solution. Subsequently the mixture was evaporated to dryness, the residue 
dissolved in dimethylformamide (about 15 ml) containing 0.56 g of iV-hydroxysuccinimide 
and the solution cooled to — 10°C. Then, with stirring, 1.03 g (5 mmoles) of dicyclo­
hexylcarbodiimide were added. Stirring was continued at —10° during 2 hours before 
the reaction mixture was placed in the refrigerator. After 16 hours, the cold solution was 
filtered and evaporated in vacuo. The residue, upon dissolution in ethyl acetate, deposited
1 8  B. J. Hunt and W. Rigby, Chem. and Ind. 1967, 1868.
1 9  E. Wünsch and J. Jentsch, Chem. Ber. 97, 2490 (1964).
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a small amount of dicyclohexylurea which was removed by fïltration. The filtrate was 
extracted with water, citric acid and bicarbonate solution as above and, after drying. 
left the product as an oil on evaporation. It changed into a crisp foam upon drying ii 
high vacuum and proved chromatographically pure TS : RF =  0.78 (chloroform —ben­
zene =  1:1). Yield: 94.2%.
b) Hydrazide (XIV). 2.85 g (4.5 mmoles) of the methyl ester were dissolved in 15 ml 
of methanol, containing 1.46 ml (13.5 mmoles) of hydrazine hydrate and left for three 
days at room temperature. The hydrazide crystallized upon addition of water and 
appeared pure on TLC. It was dried in a vacuum desiccator over concentrated H 2 S 04. 
For analysis it was crystallized once from aqueous methanol, [a ] , 2, 3  =  —3.0° (c =  1, 
MeOH).
Found : C 59.8 ; H 8.5 ; N 11.0 .
Calc. fo rC 32H 55N 50 8(637.80): C 60.26; H.8.69; N  10.98.
Boc-Ser(But)-Tyr(Bui)-Ser(Bu')-Met-OMe (XVI). 1.276 g (2 mmoles) of the fore- 
going protected hydrazide were dissolved in 2 0  ml of dimethylformamide, cooled to
— 30° and acidified with 5.5 mmoles of dry HC1 dissolved in peroxide-free dioxane 
(3.04 ml of a 1.81 TV-solution). 0.27 ml of tert-bxAyX nitrite was then added dropwise and 
the temperature was raised to —15°. After 10 minutes, the acid present was carefully 
neutralised by addition of 0.77 ml (5.5 mmoles) of triethylamine. To the azide solution, 
a cooled solution of 0.44 g of methionine methyl ester hydrochloride (2.2 mmoles) in
20 ml of dimethylformamide and finally 0.31 ml (2.2 mmoles) of triethylamine were 
added. The reaction mixture was left in the refrigerator for three days, filtered to remove 
triethylammonium chloride, and evaporated in a high vacuum. The residue was dissolved 
in peroxide-free ether and extracted with water, bicarbonate, citric acid, and concentrated 
sodium chloride solutions. Upon evaporation 1.44 g (93.5 %) of a foamy solid remained, 
melting at 100-102°. It was chromatographically pure. TS : RF =  0.86 (butanol -  acetic 
acid—water =  4 :1 :1 ) ;  M è 5 ’2  =  —7.3° (c =  1, MeOH).
Found : C 59.6 ; H 8.3 ; N 7.5 ; S 4.2 .
Calc. for C3gH64N 4O10S(768.99): C 59.53; H8.39; N 7.29; S4.17.
Boc-Ser(Bul)-Tyr(But)-Ser(But)-M et-N2H3 (XVII). 6.80 g (8.83 mmoles) of the 
preceeding protected tetrapeptide methyl ester were dissolved in 25 ml of methanol 
containing 3 equivalents of hydrazine hydrate (1.29 ml). The mixture was left at room 
temperature for three days. Water was added to insipient turbidity and crystallization 
occurred immediately. Filtration of the cooled suspension afforded 5.38 g (79%) of the 
hydrazide melting at 190-192°. Chromatographically homogeneous T S : RF = 0.86 
(chloroform —methanol = 4 :1 ); [a]D° =  —6.5° (c =  1, MeOH).
Found : C 58.1 ; H 8.3 ; N  10.5 ; S4.1 .
Calc. for C37H 64N 60 9S(768.98): C 57.79; H8.39; N 10.93; S4.17.
Scheme 3.
Protected [Hars]-fi-corticotrophin-(l-24)-tetracosapeptides ( X I X  and X X )  and [Har8, 
Lys11’1 s]-$-corticotrophin- (l-18)-octadecapeptide amide ( XXI I )
Condensation of the decapeptide derivatives Xa and b to the tetradecapeptide derivative 
XVIII9  and the acylation of the partially protected octapeptide amide XXI with Xb was 
performed by analogy with the procedure of Riniker20.
2 0  B. Riniker and W. Rittel, Helv. Chim. Acta 53, 513 (1970).
Synthesis o f corticotrophic peptides 92 (1973) RECUEIL 1221
The tetracosapeptide derivative XIX was purified by countercurrent distribution in 
the system CHCl3 -CCl4 -MeOH-buffer (= 5 :2 :  8 :4 -  for buffer composition see under V). 
Vfter 250 transfers, pure material was located in the elements 55-76 (K =  0.34, rmM =  64). 
The yield was 44%. TS: RF =  0.26 (BuOH-AcOH-water =  10:1:3), =  0.30 
(EtOAc-Pyr-AcOH-water =  62:21:6:11). With the latter system, the presence of the 
corresponding sulphoxide derivate (RF =  0.20 about 5 %) was detected in the product.
The compounds XX and XXII, arising from the decapeptide derivative containing 
protected hydroxyl functions (Xb), were isolated in a nearly pure state on evaporation of 
the reaction mixture and treatment with ethyl acetate. Subsequent countercurrent dis­
tribution of the tetracosapeptide XX in the same system over 450 transfers (K =  0.02, 
rma, =  7), gave pure material in 70 % yield. TS : RF =  0.27 (EtOAc-Pyr-AcOH-water = 
62:21:6:11), free from sulphoxide. [a ] £ 5  =  54° (c =  0.587, AcOH 80%).
The protected octadecapeptide amide XXII was purified in the same manner with the 
system CHCl3 -CCl4 -MeOH-buffer (7 :4 :10 :3 ), 222 transfers (K =  0.22, rmal =  40). 
Yield 75%. TS: RF =  0.63 (EtOAc-Pyr-AcOH-water =  62:21:6:11), =  0.73 
(CHCl3-MeOH = 3:1). [« ]“  =  29° (c =  0.770, AcOH 80%).
Deprotection of XI X,  X X  and X X I I :  [Har9, Lys' 7AS]-fi-corticotrophin-( 1-18)- 
ociadecapeptide amide (I) and [Hars]-fi-corticotrophin-( 1-24)-tetracosapeptide (II)
Removal of the protective groups from the three compounds was effected with 90% 
trifluoroacetic acid. Prior to use, the reagent was distilled from pure methionine (250 mg/ 
100 ml) under nitrogen, to ensure the absence of trace amounts of peroxides. The reaction 
was carried out in the dark at room temperature in an atmosphere of nitrogen.
Chromatographical estimation of the time required for the removal of the protective 
groups from the three compounds revealed that compound XIX was set free within
15 minutes as expected but that much longer times were necessary for the removal of all 
protective groups from XX and XXII. Both compounds gave two intermediates each 
which were believed to be the mono- and bis-tert-butyl ethers of the otherwise deprotected 
peptides. In the description of the chromatographic observations (see below) the spots 
corresponding to these compounds are referred to as “transient spots”. Complete removal 
of the ether functions required 8  hours for compound XX and 6  hours for XXII.
Under the conditions specified, 50 mg batches of the latter compounds were depro­
tected. The reaction mixture was concentrated after the appropriate period and the pro­
duct was precipitated with anhydrous, peroxide-free ether. The solid trifluoroacetates 
were dissolved in 0 . 1  iV-acetic acid and filtered through a column containing a weak ion 
exchanger Merckll, acetate cycle. Eluate fractions were pooled till the Folin-Ciocalteux 
reaction became negative, the solution was lyophylized and the product dried in vacuo. 
The yields were 95 % for I and 93 % for II.
The chromatographic examinations with respect to the completeness of the deprotec­
tion and the occurrence of oxidation (of methionine in position 4) were carried out on 
hand-made alumina thin layer plates (TA: Alumina Camag, with 12% of gypsum added) 
after separation with the system BuOH-AcOH-Pyr-water (38: 8 :24:30). The spots 
were detected with the chlorine-tolidine test, after the plates had been sprayed with con­
centrated ammonia and dried (for removal of residual pyridine).
Compound I, TA: RF =  0.23 (after oxidation 0.13), transient spots due to tert-butyl 
ethers 0.38 and 0.48; on cellulose (TC) with the same solvent system: RF =  0.43 (after 
oxidation 0.26), transient spots at 0.57 and 0.63; TA, as above, with the solvent BuOH- 
AcOH-water (67:10:23): RF =  0.09 transient spots at 0.24 and 0.39.
Compound II, TA: RF =  0.43 (after oxidation 0.29), transient spots at 0.49 and 0.53; 
TC: Rr  =  0.61 (after oxidation 0.37), transient spots at 0.65 and 0.70; TA: 0.24, transient 
spots at 0.43 and 0.53 (BuOH-AcOH-water =  67:10:23).
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Amino acid analyses were carried out on samples of the deprotected compounds after 
hydrolysis with 6 iV-HCl (diluted “Supra-pur” quality from Merck) for 25 hours at 105° 
Results were in accordance with the expected formulae.
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